Medical Equipment

Global Coronary Stents Market Valuation and Growth Prospects: $16.4 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the coronary stents market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Coronary Stents Market Size?

The market for coronary stents has experienced strong expansion in recent years. Its value is projected to escalate from $11.06 billion in 2024 to $11.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be ascribed to a rising preference for minimally invasive procedures, broader healthcare availability in emerging markets, increased healthcare spending, an uptick in percutaneous coronary interventions, and a growing count of cardiologists.

The coronary stents market is poised for considerable expansion in the coming years. It is projected to achieve a size of $16.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing occurrence of cardiovascular diseases, an aging global demographic, greater public awareness regarding cardiovascular health, supportive government initiatives and funding, and the rising prevalence of lifestyle-related conditions. Noteworthy trends expected over the forecast period include continuous innovations in stent technology, advancements in imaging technologies, the establishment of strategic collaborations and partnerships, new developments in stent materials, and the integration of technology with digital health.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What Core Market Drivers Are Expanding The Coronary Stents Industry?

The increasing occurrence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market in the future. These diseases encompass various conditions affecting the heart and blood vessels, such as coronary artery disease, heart failure, stroke, and hypertension. Their rise can be attributed to an aging global populace and a higher incidence of risk factors like obesity, diabetes, inactive lifestyles, unhealthy dietary habits, and stress. A coronary stent becomes necessary in such cases to widen constricted or obstructed coronary arteries, thereby enhancing blood circulation to the heart and lowering the likelihood of heart attacks. For example, in August 2022, a report from the American College of Cardiology, a US-based non-profit medical association, forecasted substantial increases in cardiovascular risk factors across the U.S. between 2025 and 2060. Diabetes is predicted to increase by 39.3% to 55 million people, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The most substantial increases in actual cardiovascular diseases are projected for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Consequently, the growing incidence of cardiovascular diseases (CVDs) is fueling the expansion of the coronary stent market.

What Segment Insights Are Highlighted In The Coronary Stents Market Report?

The coronary stentsmarket covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Which Notable Trends Are Transforming The Coronary Stents Market Outlook?

Leading companies in the coronary stent market are developing innovative products, such as drug-eluting stents, with the aim of reducing the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents that are coated with medication, designed to prevent the re-narrowing of arteries by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its enhanced design, new delivery system, and unique size options, all specifically engineered to manage challenging cases. It continues to feature the specialized coating that minimizes the risk of artery re-blockage, consistent with other XIENCE stents. This stent boasts an exceptional safety record, evidenced by over 120 clinical trials involving more than 120,000 patients.

Which Firms Are Driving Innovation Within The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Regional Trends Are Shaping Growth In The Coronary Stents Market?

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2025, By The Business Research Company

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Disposable Endoscopes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disposable-endoscopes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795